These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 12198211

  • 1. Prognostic factors in mesangioproliferative glomerulonephritis.
    Vikse BE, Bostad L, Aasarød K, Lysebo DE, Iversen BM.
    Nephrol Dial Transplant; 2002 Sep; 17(9):1603-13. PubMed ID: 12198211
    [Abstract] [Full Text] [Related]

  • 2. Clinical prognostic factors in biopsy-proven benign nephrosclerosis.
    Vikse BE, Aasarød K, Bostad L, Iversen BM.
    Nephrol Dial Transplant; 2003 Mar; 18(3):517-23. PubMed ID: 12584273
    [Abstract] [Full Text] [Related]

  • 3. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
    Ter Arkh; 2002 Mar; 74(6):11-8. PubMed ID: 12136475
    [Abstract] [Full Text] [Related]

  • 4. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
    Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ.
    Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
    [Abstract] [Full Text] [Related]

  • 5. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury.
    Andeen NK, Jefferson JA, Akilesh S, Alpers CE, Bissonnette ML, Finn LS, Higgins J, Houghton DC, Kambham N, Magil A, Najafian B, Nicosia RF, Troxell ML, Smith KD.
    Hum Pathol; 2018 Nov; 81():272-280. PubMed ID: 30420049
    [Abstract] [Full Text] [Related]

  • 6. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.
    Frimat L, Briançon S, Hestin D, Aymard B, Renoult E, Huu TC, Kessler M.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2569-75. PubMed ID: 9430853
    [Abstract] [Full Text] [Related]

  • 7. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.
    Piccoli A, Codognotto M, Tabbi MG, Favaro E, Rossi B.
    Nephrol Dial Transplant; 2010 Aug; 25(8):2583-9. PubMed ID: 20200005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T, Fernando ME, Jayakumar M.
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [Abstract] [Full Text] [Related]

  • 10. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
    Ohtake T, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Kobayashi S.
    Hypertens Res; 2008 Mar; 31(3):387-94. PubMed ID: 18497456
    [Abstract] [Full Text] [Related]

  • 11. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.
    Takei T, Itabashi M, Moriyama T, Shimizu A, Tsuruta Y, Ochi A, Nakayama K, Iwasaki C, Uchida K, Nitta K.
    Clin Exp Nephrol; 2013 Feb; 17(1):92-8. PubMed ID: 22821391
    [Abstract] [Full Text] [Related]

  • 12. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E, Akkaya BK, Akman S, Karpuzoglu G, Guven AG.
    J Nephrol; 2007 Feb; 20(2):234-45. PubMed ID: 17514629
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of immunoglobulin-associated mesangiocapillary glomerulonephritis: A South African experience.
    Chothia MY, Panday AS, Coetzee L, Bates W.
    Nephrology (Carlton); 2020 Oct; 25(10):765-774. PubMed ID: 32463170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F.
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [Abstract] [Full Text] [Related]

  • 16. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
    Okpechi IG, Dlamini TA, Duffield M, Rayner BL, Moturi G, Swanepoel CR.
    PLoS One; 2014 Mar; 9(11):e113302. PubMed ID: 25411791
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological features of membranoproliferative glomerulonephritis under a new classification.
    Nargund P, Kambham N, Mehta K, Lafayette RA.
    Clin Nephrol; 2015 Dec; 84(6):323-30. PubMed ID: 26445002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.
    Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W.
    Nephron; 1990 Dec; 55(3):242-50. PubMed ID: 2370922
    [Abstract] [Full Text] [Related]

  • 20. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Dec; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.